TESRA: (Treatment of Emphysema With a Gamma-Selective Retinoid Agonist)
Public ClinicalTrials.gov record NCT00413205. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-blind, Placebo-controlled Efficacy (as Assessed by Post-bronchodilator FEV1) and Safety Study of RAR Gamma in Subjects With Smoking-related, Moderate to Severe COPD With Emphysema Receiving Concurrent Optimised COPD Drug Therapy.
Study identification
- NCT ID
- NCT00413205
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Enrollment
- 491 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- RAR Gamma Drug
Drug
Eligibility (public fields only)
- Age range
- 44 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2006
- Primary completion
- Apr 30, 2010
- Completion
- Apr 30, 2010
- Last update posted
- Nov 1, 2016
2007 – 2010
United States locations
- U.S. sites
- 12
- U.S. states
- 10
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | 35299 | — |
| Not listed | Los Angeles | California | 90095-1690 | — |
| Not listed | San Diego | California | 92103 | — |
| Not listed | Torrance | California | 90502 | — |
| Not listed | Denver | Colorado | 80206 | — |
| Not listed | Chicago | Illinois | 60611 | — |
| Not listed | Detroit | Michigan | 48202-2689 | — |
| Not listed | Omaha | Nebraska | 68198-2465 | — |
| Not listed | Oklahoma City | Oklahoma | 73112 | — |
| Not listed | Philadelphia | Pennsylvania | 19140 | — |
| Not listed | Spartanburg | South Carolina | 29303 | — |
| Not listed | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 52 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00413205, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 1, 2016 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00413205 live on ClinicalTrials.gov.